Delivery Order SPE2DB20D2104-SPE2DB26FMADJ
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 ml pen injectors, valued at $6,777.99, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's ongoing pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order on September 3, 2025, by the Defense Logistics Agency (DLA) for DUPIXENT 300 mg/2 ml pen injectors valued at $10,570.09 under a firm fixed-price contract. The order is set to be completed by September 4, 2025, with performance conducted at the company's corporate office location in Conshohocken, Pennsylvania. This competitively awarded delivery order represents a single pharmaceutical supply transaction within DLA's medical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injectors valued at $35,018.51 under a firm fixed price contract type. The delivery order, issued on June 30, 2025, with an ultimate completion date of July 1, 2025, represents a non-competitive award to the prime contractor. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $22,738.07 firm fixed price delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injectors (2 ML). The contract was executed on July 29, 2025, with an ultimate completion date of July 30, 2025, and is being fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded contract issued under the company's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $8,632.83 to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injectors (2ML). The contract, executed on August 28, 2025, with completion targeted for August 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order through competitive procurement processes. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injectors valued at $7,550.30 under a firm fixed price contract. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of DUPIXENT 300 mg/2 ml pen injectors at a firm fixed price of $3,418.92. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 1, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $16,252.69 delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 mg/2 mL pens on August 22, 2025, with an ultimate completion date of August 25, 2025. This non-set-aside, firm fixed price contract represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The award is performed from the vendor's Conshohocken, Pennsylvania location, the company's corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a $16,338.29 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors under a firm fixed-price contract type. This award, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive delivery against an existing indefinite delivery contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical...
- The Defense Logistics Agency awarded a $26,840.77 delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injectors on September 24, 2025, with completion scheduled for September 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical products will be performed at the company's corporate...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB26FMADJDelivery Order
The Defense Logistics Agency awarded a $4,810.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DUPIXENT 300 MG/2 ML pen injectors (2 ML) on October 16, 2025, with an ultimate completion date of October 17, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement fulfilling immediate medical supply needs within the federal healthcare system. The award was placed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement establishes a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad spectrum of medications, specialty drugs, vaccines, and medical supplies to support military healthcare programs and other federal health systems worldwide. The IDC structure allows DLA to issue multiple delivery orders for specific pharmaceutical products as needed, ensuring responsive supply chain support for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare customers across various therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 10/16/25 |